Immutrix Therapeutics' Convertible Note Round

Immutrix Therapeutics raised a round of funding on August 31, 2019.

ImmutriX Therapeutics develops a medical device for cleansing whole blood to modulate and sequester molecules from circulation known to be contrary to health. ImmutriX products target and bind molecu…

Articles about Immutrix Therapeutics' Convertible Note Round: